Information on germline BRCA (g* BRCA*) 1/2 pathogenic or likely pathogenic mutations
has predictive value for response to platinating agents and poly (ADP-ribose) polymerase …

Providers of women's health services are often confronted with questions about cancer
genetic testing. The provision of these services is complex. The process begins with …

The aim of this study was to examine the patterns of disclosure of BRCA1/2 genetic test
results to employers by unaffected carriers. In a national prospective cohort study on …

Genetic testing for hereditary cancer syndromes is becoming increasingly more common.
Once a mutation is detected in a family, other family members can undergo single-site …

Direct observation shows how traditional narrow biomedical conceptions of truth in
medicine, coupled with increasing technological sophistication and the consequent …

O cancro da mama é o cancro mais frequente em mulheres. Do total de casos de cancro da
mama, 10 a 15% são hereditários, isto é, são causados por mutações em genes de …

Breast surgery has evolved as a subspecialty of general surgery and requires a working
knowledge of benign and malignant diseases, surgical techniques, shared decision-making …

The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal
disorders caused by somatic driver mutations affecting the hematopoietic stem and …

Introduction The timely identification of breast cancer-related pathogenic variants can help to
identify the risk of potential disease development and determine healthcare choices …

Introduction The timely identification of breast cancerrelated pathogenic variants can help to
identify the risk of potential disease development and determine healthcare choices …